Belize - Press Releases

SHELTON, Conn., March 13, 2025 /PRNewswire/ --Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies designed to kill tumors and increase immune system recognition of cancers, announces 2024 year-end financial results and provides a corporate update.

COCONUT GROVE, Fla., March 13, 2025 /PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL, NXPLW) ("NextPlat" or the "Company"), a global e-Commerce provider, today announced that it has rescheduled the release of its financial results for the full-year ended December 31, 2024, to before market open on March 24, 2025.

RA'ANANA, Israel, March 13, 2025 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that on March 10, 2025, the Company received a written notice (the "Notice") from the Nasdaq Stock Market LLC indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2), as the Company's closing bid price for its ordinary shares, or Ordinary Shares, was below $1.00 per share for the last 30 consecutive business days.

FORT WORTH, Texas, March 13, 2025 /PRNewswire/ --According toCDC, more than 222 measles cases have been reported across 12 states as of this press release.

As VERZENIO gains traction in early-stage treatments and broadens its approved uses, its revenue is expected to keep growing. While the global CDK4/6 inhibitor market remains highly competitive, VERZENIO's distinct clinical advantages and ongoing studies could contribute to further market expansion.

SAN FRANCISCO, March 13, 2025 /PRNewswire/ -- Hyde Park Capitalannounced today that its client, Infiniti Medical LLC(and its subsidiary Orthomed UK Ltd), two globally recognized brands specializing in veterinary interventional radiology, cardiology, soft tissue surgery, and orthopedics,has been acquired by Creative Science, a CIMA Animal Healthcompany, and a leader in veterinary medical solutions. CIMA Animal Health, a portfolio company of Incline Equity Partners, is dedicated to improving the lives of animals and those who care for them. Hyde Park Capital, led by Managing Director Craig Lawson, served as the exclusive financial advisor to Infiniti Medical for this transaction.

A case study on how DelveInsight helped a pharma client navigate the evolving metabolic dysfunction-associated steatohepatitis (MASH) landscape with actionable market intelligence

PORTLAND, Ore, March 13, 2025 /PRNewswire/ -- Ann Sacks, an industry leader in luxury tile and stone, is pleased to announce the opening of its latest showroom and slab gallery, Ann Sacks Charlotte, 721 Gov Morrison Street, Unit 110A, Charlotte, NC 28211, phone number (980) 316-3996. The Ann Sacks Showroom and Slab Gallery is open Monday through Friday, 9:00 a.m. to 5:00 p.m., and Saturdays by appointment. Catering to designers and consumers seeking out the finest in home furnishings, South Park was a natural fit for Ann Sacks Charlotte and the range of brands one can experience under its roof.

PLYMOUTH MEETING, Pa., March 13, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced promising interim results from an ongoing Phase 1 proof-of-concept trial evaluating DMAbs for COVID-19. In the trial, 100% (24/24) of participants who have reached week 72 maintained biologically relevant levels of DMAbs, confirming the durability of in vivo antibody production. Notably, no participant developed anti-drug antibodies (ADA), a common challenge observed in other gene-based delivery platforms, such as adeno-associated virus (AAV) mediated antibody expression. Additionally, the DMAbs were well tolerated, with the most common side effects being mild, temporary injection site reactions, such as pain and redness. The trial is being led by The Wistar Institute in collaboration with INOVIO, AstraZeneca, and clinical investigators at the Perelman School of Medicine at the University of Pennsylvania.

DALLAS, March 13, 2025 /PRNewswire/ --Nanoscope Therapeutics Inc., a biotech company committed to restoring vision in individuals who are blind or losing vision due to various retinal degenerative diseases, today announced that Sulagna Bhattacharya, Chief Executive Officer and Co-Founder of Nanoscope Therapeutics, will present at the H.C. Wainwright 3rd Annual BioConnect Showcase, taking place March 16-18, 2025, on Kiawah Island, SC. Details for the presentation are as follows:

SEATTLE, March 13, 2025 /PRNewswire/ --Washington Poison Center (WAPC), Washington's nonprofit service for free medical advice on poisoning and drug overdoses, is pleased to announce the four winners of its 19th annual Poison Prevention Poster Contest:

SIRUM's pharmacy service, Good Pill Pharmacy, will offer 500+ low-cost medications to anyone in Maryland whose medication costs are too high

RANCHO CUCAMONGA, Calif., March 13, 2025 /PRNewswire/ -- Inland Empire Health Plan (IEHP), the California Community College system and the San Bernardino Community College District (SBCCD) are partnering to connect local college students to low-cost, high-quality health care and CalFresh programs. Known as the Inland Empire Health Plan Equitable Support Demonstration Project, the collaboration is the first of its kind and will serve as a pilot program for other counties across the state.

LINKPING,Sweden, March 14, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra's(STO: SECT B) enterprise imaging module for radiology is ranked number one by users around the world. We also have the most satisfied customers in digital pathology. Our commitment to customer satisfaction is the foundation of our success in all operating areas. The operating profit trend for the Group is positive despite the ongoing transition to service sales. A settlement was also reached in the third quarter regarding Sectra's patented technology for secure communication, which had a positive non-recurring effect on the Group's financial outcomes.

LINKPING,Sweden, March 14, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra's(STO: SECT B) enterprise imaging module for radiology is ranked number one by users around the world. We also have the most satisfied customers in digital pathology. Our commitment to customer satisfaction is the foundation of our success in all operating areas. The operating profit trend for the Group is positive despite the ongoing transition to service sales. A settlement was also reached in the third quarter regarding Sectra's patented technology for secure communication, which had a positive non-recurring effect on the Group's financial outcomes.

NEW YORK and SUZHOU, China, March 14, 2025 /PRNewswire/ -- Accropeutics Inc. (Accropeutics), a clinical-stage biotechnology company pioneering the development of novel therapeutics that target molecular mechanisms of regulated cell death for immune mediated diseases, today announced the closing of its $12 million Series B Plus financing. The round was led by Shenzhen Capital Group (SCGC), an existing investor, with participation from Morningside Ventures, also an existing investor, and new investors Leader Venture Investment (SZTI) and Hefei Sci-Tec Venture Capital (HFST).

Targeted Multi-Medium Ads feature Donald Trump Jr., Ted Nugent, Brett Favre, other celebrities and influencers urging hunters and 2nd Amendment activists to vote for Judge Schimel on April 1st.

DENVER, March 13, 2025 /PRNewswire/ -- Ursa Major has been awarded a contract for delivery of fully integrated GEO propulsion systems for a customer focused on critical space missions. The multi-year award totaling $10 to $15 million supports the development, manufacturing, assembly, integration, and testing of a full propulsion system capable of six degree-of-freedom maneuverability.

BANGKOK, March 14, 2025 /PRNewswire/ -- The Department of International Trade Promotion (DITP), Ministry of Commerce, in collaboration with the Board of Trade of Thailand, proudly presents STYLE Bangkok 2025, the region's most anticipated lifestyle and fashion trade fair. Taking place from 2-6 April 2025 at Queen Sirikit National Convention Center (QSNCC), Bangkok, this international platform showcases Thailand's dynamic creative economy, design excellence, and sustainable innovations.

SEOUL, South Korea, March 14, 2025 /PRNewswire/ --Coway Co., Ltd., the "Best Life Solution Company," announced today that its NOBLE 2.0 Air Purifier series has been honored by the International Forum (iF) Design Award 2025 in the Product Design category.

GUANGZHOU, China, March 14, 2025 /PRNewswire/ -- The 137th Canton Fair is coming this April. Recognized as the largest trade fair in China, the fair successfully conducted a Middle East roadshow in February, with trade promotion events in Qatar, Saudi Arabia and United Arab Emirates.

OSLO, Norway, March 14, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of the study "Oncologic Outcomes of Blue Light Cystoscopy in an Equal Access Setting: Results of the BRAVO study" in JU Open Plus this week. The research objective was to assess ifblue light cystoscopy (BLC) aided TURBT has an impact on the clinical outcomes of patients with NMIBC*. Results of the real-world evidence study show that BLC was associated with a statistically significant 38% reduction in risk of recurrence compared to white light cystoscopy (WLC) use alone in a predominantly high-risk NMIBC patient cohort. These results are in line with prior results from multiple randomized controlled clinical trials.

OSLO, Norway, March 14, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the publication of the study "Oncologic Outcomes of Blue Light Cystoscopy in an Equal Access Setting: Results of the BRAVO study" in JU Open Plus this week. The research objective was to assess ifblue light cystoscopy (BLC) aided TURBT has an impact on the clinical outcomes of patients with NMIBC*. Results of the real-world evidence study show that BLC was associated with a statistically significant 38% reduction in risk of recurrence compared to white light cystoscopy (WLC) use alone in a predominantly high-risk NMIBC patient cohort. These results are in line with prior results from multiple randomized controlled clinical trials.

GUANGZHOU, Chine, 14 mars 2025 /PRNewswire/ -- La 55e dition du Salon international du meuble de Chine (CIFF Guangzhou 2025) se droulera en deux phases au complexe de la Foire de Canton Guangzhou, du 18 au 21 mars et du 28 au 31 mars 2025.

GUANGZHOU, China, 14. Mrz 2025 /PRNewswire/ -- Die 55.Ausgabe der China International Furniture Fair (Guangzhou) (CIFF Guangzhou 2025) wird in zwei Phasen vom 18. bis 21.Mrz und vom 28. bis 31.Mrz 2025 im Canton Fair Complex in Guangzhou stattfinden.